首页 > 最新文献

Mycopathologia最新文献

英文 中文
Disseminated Cutaneous Sporotrichosis in an Immunocompetent Patient. 免疫功能正常患者弥散性皮肤孢子菌病。
IF 2.9 3区 生物学 Q2 MYCOLOGY Pub Date : 2025-10-06 DOI: 10.1007/s11046-025-01006-9
Ruixin Deng, Tianyi Xu, Yalong Li, Shaoqin Zhou, Aiping Wang, Yinggai Song
{"title":"Disseminated Cutaneous Sporotrichosis in an Immunocompetent Patient.","authors":"Ruixin Deng, Tianyi Xu, Yalong Li, Shaoqin Zhou, Aiping Wang, Yinggai Song","doi":"10.1007/s11046-025-01006-9","DOIUrl":"10.1007/s11046-025-01006-9","url":null,"abstract":"","PeriodicalId":19017,"journal":{"name":"Mycopathologia","volume":"190 6","pages":"97"},"PeriodicalIF":2.9,"publicationDate":"2025-10-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145233090","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Mycobiome of Stool, Blood, Thrombus and Vessel Wall in Abdominal Aortic Aneurysm Patients. 腹主动脉瘤患者粪便、血液、血栓及血管壁的菌群。
IF 2.9 3区 生物学 Q2 MYCOLOGY Pub Date : 2025-10-03 DOI: 10.1007/s11046-025-01002-z
Éva Nemes-Nikodém, Gergő Péter Gyurok, Zsuzsanna A Dunai, Nóra Makra, Bálint Hofmeister, Dóra Szabó, László Hidi, Ágnes Szappanos, Gergely Imre Kovács, Péter Sótonyi, Eszter Ostorházi

Abdominal aortic aneurysm (AAA) is a life-threatening vascular condition characterized by inflammatory degeneration of the vessel wall. Emerging evidence suggests that microbial factors contribute to its progression. In this study, we analyzed the mycobiome composition of stool, blood, thrombus and damaged vessel wall samples collected during surgery from 24 AAA patients using Internal Transcribed Spacer (ITS) sequencing. Significant differences in alpha and beta diversity were observed across the sample types, confirming compartmentalization of the mycobiome. However, individual fungal profiles did not establish a clear gut-blood-vessel wall axis, indicating that fungi translocated to the vessel wall may originate from other anatomical regions. Comparison AAA mycobiome with healthy arterial walls' mycobiome from organ donors revealed a dominance of anti-inflammatory Tomentella in healthy samples, while pro-inflammatory Malassezia species were prevalent in damaged vessel walls. These findings highlight the role of fungi in AAA progression and suggest potential thera-peutic avenues, including antifungal adjuvant treatments to mitigate inflammation and aneurysm development.

腹主动脉瘤(AAA)是一种危及生命的血管疾病,其特征是血管壁的炎症变性。新出现的证据表明,微生物因素有助于其进展。在这项研究中,我们使用内部转录间隔器(ITS)测序分析了24例AAA患者手术期间收集的粪便、血液、血栓和受损血管壁样本的真菌组组成。在不同的样品类型中观察到α和β多样性的显著差异,证实了真菌群落的区隔化。然而,个别真菌谱并没有建立一个明确的肠道-血管壁轴,这表明真菌易位到血管壁可能起源于其他解剖区域。将AAA菌群与来自器官供体的健康动脉壁的菌群进行比较,发现健康样本中抗炎的托门氏菌占优势,而在受损血管壁中,促炎的马拉色菌普遍存在。这些发现强调了真菌在AAA进展中的作用,并提出了潜在的治疗途径,包括抗真菌辅助治疗,以减轻炎症和动脉瘤的发展。
{"title":"Mycobiome of Stool, Blood, Thrombus and Vessel Wall in Abdominal Aortic Aneurysm Patients.","authors":"Éva Nemes-Nikodém, Gergő Péter Gyurok, Zsuzsanna A Dunai, Nóra Makra, Bálint Hofmeister, Dóra Szabó, László Hidi, Ágnes Szappanos, Gergely Imre Kovács, Péter Sótonyi, Eszter Ostorházi","doi":"10.1007/s11046-025-01002-z","DOIUrl":"10.1007/s11046-025-01002-z","url":null,"abstract":"<p><p>Abdominal aortic aneurysm (AAA) is a life-threatening vascular condition characterized by inflammatory degeneration of the vessel wall. Emerging evidence suggests that microbial factors contribute to its progression. In this study, we analyzed the mycobiome composition of stool, blood, thrombus and damaged vessel wall samples collected during surgery from 24 AAA patients using Internal Transcribed Spacer (ITS) sequencing. Significant differences in alpha and beta diversity were observed across the sample types, confirming compartmentalization of the mycobiome. However, individual fungal profiles did not establish a clear gut-blood-vessel wall axis, indicating that fungi translocated to the vessel wall may originate from other anatomical regions. Comparison AAA mycobiome with healthy arterial walls' mycobiome from organ donors revealed a dominance of anti-inflammatory Tomentella in healthy samples, while pro-inflammatory Malassezia species were prevalent in damaged vessel walls. These findings highlight the role of fungi in AAA progression and suggest potential thera-peutic avenues, including antifungal adjuvant treatments to mitigate inflammation and aneurysm development.</p>","PeriodicalId":19017,"journal":{"name":"Mycopathologia","volume":"190 6","pages":"96"},"PeriodicalIF":2.9,"publicationDate":"2025-10-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12494604/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145213188","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Character Virulence Association Factors and Gene Mutation Mediating Multidrug Resistance Phenotypes in Candidozyma duobushaemulonii. 双色念珠菌的性状、毒力、关联因素及介导多药耐药表型的基因突变
IF 2.9 3区 生物学 Q2 MYCOLOGY Pub Date : 2025-10-03 DOI: 10.1007/s11046-025-01008-7
Hao Zhou, Xi Yang, Quan Zhou, Cai Hu, Caiyan Xin, Zhangyong Song

Candidiasis, traditionally dominated by Candida albicans infection, now faces a paradigm shift with the emergence of non-C. albicans infections, such as the multidrug-resistant (MDR) Candidozyma (formerly Candida) species. Critically, the emergence of multidrug resistance (MDR) Candidozyma duobushaemulonii (also known as Candida duobushaemulonii) poses critical challenges to antifungal therapy. Here, in this comparative study, we analyzed four clinical C. duobushaemulonii isolates (cd, cd1, cd2, and cd3) to establish strain-specific virulence and antifungal resistance profiles. Biofilm quantification using crystal violet (CV) and 2,3-Bis-(2-methoxy-4-nitro-5-sulfophenyl)-2H-tetrazolium-5-carboxanilide (XTT) metabolic activity assays showed different biomass production levels across strains. Cellular aggregation capacity differed significantly, while cell surface hydrophobicity (CSH) showed inverse patterns. In Galleria mellonella infection models, virulence stratification was observed. Antifungal susceptibility testing revealed minimum inhibitory concentration (MIC) azole gradients. MDR in the cd1 strain extended to 5-fluorocytosine (5-FC) and anidulafungin (ANI), whereas the cd3 strain showed intermediate posaconazole (PSZ) resistance distinct to the cd2 strain. Amino acid sequence analyses indicated that Y132F substitutes in ERG11 and D139N in FUR1 genes occurred in cd and cd1 strains. Gene expression analysis recorded various regulatory situations among strains. These analyses provide a complete resistance-virulence matrix for C. duobushaemulonii, establishing baseline characteristics for epidemiological surveillance and a reference framework for future comparative studies.

念珠菌病,传统上以白色念珠菌感染为主,现在面临着一个范式转变与非c的出现。白色念珠菌感染,如多重耐药(MDR)念珠菌(原念珠菌)物种。至关重要的是,多重耐药(MDR)假丝酵母(也称为假丝酵母)的出现对抗真菌治疗提出了严峻的挑战。在这项比较研究中,我们分析了四种临床分离的双雄乳香杆菌(cd, cd1, cd2和cd3),以建立菌株特异性毒力和抗真菌耐药性谱。采用结晶紫(CV)和2,3-二-(2-甲氧基-4-硝基-5-磺胺基)- 2h -四氮唑-5-羧基苯胺(XTT)代谢活性测定的生物膜定量结果显示,不同菌株的生物量生产水平不同。细胞聚集能力差异显著,而细胞表面疏水性(CSH)呈相反规律。在mellonella感染模型中,观察到毒力分层。抗真菌药敏试验显示最小抑菌浓度(MIC)为唑类梯度。cd1菌株的耐药范围扩展到5-氟胞嘧啶(5-FC)和阿尼杜拉芬素(ANI),而cd3菌株则表现出与cd2菌株不同的泊沙康唑(PSZ)中间耐药性。氨基酸序列分析表明,cd和cd1菌株在FUR1基因的ERG11和D139N中存在Y132F替代。基因表达分析记录了菌株间不同的调控情况。这些分析提供了一份完整的双色棘球蚴耐药性-毒力矩阵,为流行病学监测建立了基线特征,并为今后的比较研究提供了参考框架。
{"title":"Character Virulence Association Factors and Gene Mutation Mediating Multidrug Resistance Phenotypes in Candidozyma duobushaemulonii.","authors":"Hao Zhou, Xi Yang, Quan Zhou, Cai Hu, Caiyan Xin, Zhangyong Song","doi":"10.1007/s11046-025-01008-7","DOIUrl":"10.1007/s11046-025-01008-7","url":null,"abstract":"<p><p>Candidiasis, traditionally dominated by Candida albicans infection, now faces a paradigm shift with the emergence of non-C. albicans infections, such as the multidrug-resistant (MDR) Candidozyma (formerly Candida) species. Critically, the emergence of multidrug resistance (MDR) Candidozyma duobushaemulonii (also known as Candida duobushaemulonii) poses critical challenges to antifungal therapy. Here, in this comparative study, we analyzed four clinical C. duobushaemulonii isolates (cd, cd1, cd2, and cd3) to establish strain-specific virulence and antifungal resistance profiles. Biofilm quantification using crystal violet (CV) and 2,3-Bis-(2-methoxy-4-nitro-5-sulfophenyl)-2H-tetrazolium-5-carboxanilide (XTT) metabolic activity assays showed different biomass production levels across strains. Cellular aggregation capacity differed significantly, while cell surface hydrophobicity (CSH) showed inverse patterns. In Galleria mellonella infection models, virulence stratification was observed. Antifungal susceptibility testing revealed minimum inhibitory concentration (MIC) azole gradients. MDR in the cd1 strain extended to 5-fluorocytosine (5-FC) and anidulafungin (ANI), whereas the cd3 strain showed intermediate posaconazole (PSZ) resistance distinct to the cd2 strain. Amino acid sequence analyses indicated that Y132F substitutes in ERG11 and D139N in FUR1 genes occurred in cd and cd1 strains. Gene expression analysis recorded various regulatory situations among strains. These analyses provide a complete resistance-virulence matrix for C. duobushaemulonii, establishing baseline characteristics for epidemiological surveillance and a reference framework for future comparative studies.</p>","PeriodicalId":19017,"journal":{"name":"Mycopathologia","volume":"190 6","pages":"95"},"PeriodicalIF":2.9,"publicationDate":"2025-10-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145213270","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Optimization of the Genome Editing CRISPR-Cas9 Technology in Scedosporium apiospermum. 尖孢梭孢基因组编辑CRISPR-Cas9技术的优化
IF 2.9 3区 生物学 Q2 MYCOLOGY Pub Date : 2025-09-30 DOI: 10.1007/s11046-025-00998-8
Kévin Ravenel, Wilfried Poirier, Bienvenue Razafimandimby, Jean-Philippe Bouchara, Amandine Gastebois, Sandrine Giraud

Scedosporium species are opportunistic pathogens causing a large variety of human infections. To date, there is limited information on the pathogenic mechanisms of these fungi, partly because of the limited number of genetic tools available. Here, the CRISPR-Cas9 technology, which provided promising results for functional genomic studies in filamentous fungi, was optimized for Scedosporium species using in vitro assembled Cas9 ribonucleoprotein (RNP) complexes. In these fungi, functional genomic studies are particularly complex in a wild-type strain, because of the high frequency of non-homologous recombination. Prior disruption of the KU70 gene encoding one of the components of the non-homologous end joining system is required, which necessitates the use of a first selection marker. The cleavage of the target gene at each end using a dual RNA-guided Cas9 complex, followed by recombination with a repair template containing the hygromycin resistance gene, allowed disruption of the target gene in the ΔKU70 mutant. Four genes encoding dioxygenases, catalyzing the critical ring-opening step in aromatic hydrocarbons, were successfully disrupted, and the optimum efficiency was observed using 5 μg of the HygR repair cassette. Alternatively, in the wild-type strain, the exclusive use of two Cas9 RNP complexes was enough to achieve an efficient deletion method; one dioxygenase gene was successfully deleted in up to 20% of the obtained colonies. These last experimental conditions path the way to multiple gene deletions and complementation experiments, which cannot be reached using our first procedure since only two selection markers are available for Scedosporium species.

隐孢子菌是一种机会致病菌,可引起各种各样的人类感染。迄今为止,关于这些真菌的致病机制的信息有限,部分原因是可用的遗传工具数量有限。本研究利用体外组装的Cas9核糖核蛋白(RNP)复合物对丝状真菌的功能基因组研究进行了优化,为丝状真菌的功能基因组研究提供了有希望的结果。在这些真菌中,由于非同源重组的高频率,在野生型菌株中进行功能基因组研究特别复杂。编码非同源末端连接系统组分之一的KU70基因需要事先被破坏,这就需要使用第一选择标记。使用双rna引导的Cas9复合物在两端切割靶基因,然后与含有湿霉素抗性基因的修复模板重组,允许在ΔKU70突变体中破坏靶基因。成功地破坏了4个编码双加氧酶的基因,并在5 μg的HygR修复盒中观察到最佳效率。或者,在野生型菌株中,仅使用两个Cas9 RNP复合物就足以实现有效的删除方法;在获得的菌落中,有20%的双加氧酶基因被成功地删除。这些最后的实验条件为多基因缺失和互补实验铺平了道路,这是我们的第一个程序无法达到的,因为只有两个选择标记可用于Scedosporium物种。
{"title":"Optimization of the Genome Editing CRISPR-Cas9 Technology in Scedosporium apiospermum.","authors":"Kévin Ravenel, Wilfried Poirier, Bienvenue Razafimandimby, Jean-Philippe Bouchara, Amandine Gastebois, Sandrine Giraud","doi":"10.1007/s11046-025-00998-8","DOIUrl":"10.1007/s11046-025-00998-8","url":null,"abstract":"<p><p>Scedosporium species are opportunistic pathogens causing a large variety of human infections. To date, there is limited information on the pathogenic mechanisms of these fungi, partly because of the limited number of genetic tools available. Here, the CRISPR-Cas9 technology, which provided promising results for functional genomic studies in filamentous fungi, was optimized for Scedosporium species using in vitro assembled Cas9 ribonucleoprotein (RNP) complexes. In these fungi, functional genomic studies are particularly complex in a wild-type strain, because of the high frequency of non-homologous recombination. Prior disruption of the KU70 gene encoding one of the components of the non-homologous end joining system is required, which necessitates the use of a first selection marker. The cleavage of the target gene at each end using a dual RNA-guided Cas9 complex, followed by recombination with a repair template containing the hygromycin resistance gene, allowed disruption of the target gene in the ΔKU70 mutant. Four genes encoding dioxygenases, catalyzing the critical ring-opening step in aromatic hydrocarbons, were successfully disrupted, and the optimum efficiency was observed using 5 μg of the HygR repair cassette. Alternatively, in the wild-type strain, the exclusive use of two Cas9 RNP complexes was enough to achieve an efficient deletion method; one dioxygenase gene was successfully deleted in up to 20% of the obtained colonies. These last experimental conditions path the way to multiple gene deletions and complementation experiments, which cannot be reached using our first procedure since only two selection markers are available for Scedosporium species.</p>","PeriodicalId":19017,"journal":{"name":"Mycopathologia","volume":"190 6","pages":"94"},"PeriodicalIF":2.9,"publicationDate":"2025-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145192278","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
In-Hospital Mortality Among Hematological Malignancy Patients Undergoing Bronchoscopy for Suspected Invasive Pulmonary Aspergillosis: Focusing on Coinfections and Nodules on Chest CT. 疑似侵袭性肺曲霉病行支气管镜检查的血液恶性肿瘤患者的住院死亡率:重点关注胸部CT上的合并感染和结节。
IF 2.9 3区 生物学 Q2 MYCOLOGY Pub Date : 2025-09-29 DOI: 10.1007/s11046-025-01005-w
N A Acet-Öztürk, D Ömer-Topçu, K V Acar, Ö Aydın-Güçlü, I E Pınar, E Demirdöğen, A Görek-Dilektaşlı, E Kazak, V Özkocaman, A Ursavas, F Özkalemkaş, B Ener, R Ali, H Akalın

Introduction: Invasive pulmonary aspergillosis (IPA) in hematological malignancy populations has high mortality rates. While there are identified prognostic factors for mortality, conflicting results are reported from the studies including bronchoalveolar lavage galactomannan (GM) measurements and co-infections. We aimed to evaluate risk factors associated with in-hospital mortality in a hematological malignancy population undergoing bronchoscopy with a preliminary diagnosis of IPA in a single tertiary care center.

Method: Patients undergoing bronchoscopy with a preliminary diagnosis of IPA were included in this retrospective study. Bacterial co-infection was defined as a positive bacterial culture in respiratory samples within ± 7 days of the index bronchoscopy procedure.

Results: Study population consisted 305 patients diagnosed as possible, probable or proven IPA. 57 patients presented with fungal and bacterial co-infection. In-hospital mortality was observed in 98 (33.6%) patients. Patients with mortality status were older and were not in remission for hematological malignancy. Serum GM, bronchoalveolar lavage (BAL) GM and bronchial lavage (BL) GM levels showed a significant relation with in-hospital mortality but weak accuracy. In multivariate analysis for risk factors of in-hospital mortality; age, remission status, number of nodules in HRCT and having fungal infections with or without combined bacterial infection were independent risk factors.

Conclusion: Co-infections in this susceptible population should not be overlooked even in the presence of fungal infection evidence. BAL and BL GM tended to have a stronger relation with survival than serum GM measurements taken at the same time. The number of nodules in radiological assessment might be an indicator of mortality. Radiological changes through the disease course might be assessed in further studies.

简介:侵袭性肺曲霉病(IPA)在血液恶性肿瘤人群中具有很高的死亡率。虽然已经确定了死亡率的预后因素,但从支气管肺泡灌洗半乳甘露聚糖(GM)测量和合并感染等研究中报告的结果相互矛盾。我们的目的是评估在单一三级医疗中心接受支气管镜检查并初步诊断为IPA的血液恶性肿瘤人群中与住院死亡率相关的危险因素。方法:回顾性分析经支气管镜检查初步诊断为IPA的患者。细菌合并感染定义为在支气管镜检查后±7天内呼吸道样本中细菌培养阳性。结果:研究人群包括305名被诊断为可能、可能或证实IPA的患者。57例患者出现真菌和细菌合并感染。98例(33.6%)患者住院死亡。死亡状态的患者年龄较大,血液系统恶性肿瘤未缓解。血清GM、支气管肺泡灌洗(BAL) GM和支气管灌洗(BL) GM水平与住院死亡率有显著相关性,但准确性较低。住院死亡危险因素的多因素分析年龄、缓解状态、HRCT结节数、有无真菌感染合并细菌感染是独立的危险因素。结论:即使存在真菌感染的证据,也不应忽视易感人群的合并感染。与同时测定血清GM相比,BAL和BL GM与生存的关系更密切。放射学评估中结节的数量可能是死亡率的一个指标。在进一步的研究中可以评估病程中的放射学变化。
{"title":"In-Hospital Mortality Among Hematological Malignancy Patients Undergoing Bronchoscopy for Suspected Invasive Pulmonary Aspergillosis: Focusing on Coinfections and Nodules on Chest CT.","authors":"N A Acet-Öztürk, D Ömer-Topçu, K V Acar, Ö Aydın-Güçlü, I E Pınar, E Demirdöğen, A Görek-Dilektaşlı, E Kazak, V Özkocaman, A Ursavas, F Özkalemkaş, B Ener, R Ali, H Akalın","doi":"10.1007/s11046-025-01005-w","DOIUrl":"10.1007/s11046-025-01005-w","url":null,"abstract":"<p><strong>Introduction: </strong>Invasive pulmonary aspergillosis (IPA) in hematological malignancy populations has high mortality rates. While there are identified prognostic factors for mortality, conflicting results are reported from the studies including bronchoalveolar lavage galactomannan (GM) measurements and co-infections. We aimed to evaluate risk factors associated with in-hospital mortality in a hematological malignancy population undergoing bronchoscopy with a preliminary diagnosis of IPA in a single tertiary care center.</p><p><strong>Method: </strong>Patients undergoing bronchoscopy with a preliminary diagnosis of IPA were included in this retrospective study. Bacterial co-infection was defined as a positive bacterial culture in respiratory samples within ± 7 days of the index bronchoscopy procedure.</p><p><strong>Results: </strong>Study population consisted 305 patients diagnosed as possible, probable or proven IPA. 57 patients presented with fungal and bacterial co-infection. In-hospital mortality was observed in 98 (33.6%) patients. Patients with mortality status were older and were not in remission for hematological malignancy. Serum GM, bronchoalveolar lavage (BAL) GM and bronchial lavage (BL) GM levels showed a significant relation with in-hospital mortality but weak accuracy. In multivariate analysis for risk factors of in-hospital mortality; age, remission status, number of nodules in HRCT and having fungal infections with or without combined bacterial infection were independent risk factors.</p><p><strong>Conclusion: </strong>Co-infections in this susceptible population should not be overlooked even in the presence of fungal infection evidence. BAL and BL GM tended to have a stronger relation with survival than serum GM measurements taken at the same time. The number of nodules in radiological assessment might be an indicator of mortality. Radiological changes through the disease course might be assessed in further studies.</p>","PeriodicalId":19017,"journal":{"name":"Mycopathologia","volume":"190 6","pages":"93"},"PeriodicalIF":2.9,"publicationDate":"2025-09-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145186399","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Mortality and Treatment Outcomes in Pediatric Malignancy Patients with Invasive Cutaneous Fungal Infections: Evaluating the Impact of Combination Therapy and Surgical Debridement, Experience from Referral Oncology Teaching Hospital. 儿童恶性肿瘤侵袭性皮肤真菌感染的死亡率和治疗结果:评估联合治疗和手术清创的影响,来自转诊肿瘤教学医院的经验。
IF 2.9 3区 生物学 Q2 MYCOLOGY Pub Date : 2025-09-26 DOI: 10.1007/s11046-025-01004-x
Seyed Reza Abdipour Mehrian, Hadi Mottaghipisheh, Hadis Jafarian, Fatemeh Homayounifar, Alireza Abbasi, Yaser Pourasghar, Fateme Noushadi, Armina Farkarian, Elahe Meftah, Sadra Valiee, Ali Amanati

Background and aims: Invasive cutaneous fungal infections (ICFIs) are life-threatening complications in pediatric cancer patients. This study aimed to investigate the prevalence, clinical characteristics, and outcomes of ICFIs among pediatric cancer patients hospitalized at a referral oncology teaching Hospital in Shiraz, Iran.

Methods: This cross-sectional study included pediatric patients with malignancies and suspected ICFIs who were admitted to the Amir Oncology Teaching Hospital between 2015 and 2022. Diagnosis was based on the EORTC/MSG criteria and confirmed using clinical, microbiological, and histopathological methods. Data were analyzed using descriptive statistics, Kaplan-Meier survival analysis, and comparative tests, with a significance threshold of p < 0.05.

Results: Among the 24 patients, 58.3% were boys, and 45.8% were aged 1-5 years. Acute lymphoblastic leukemia was the most common malignancy (27.3%). Mucoralean fungi (36.4%) and Aspergillus (59.1%) were the most common. The overall survival rate was 54.2%. Proven ICFIs had the poorest outcomes, with a survival probability declining to zero by month 26. Patients with lower CRP levels and febrile neutropenia had better outcomes (p < 0.001 and p = 0.041, respectively), but survival rates did not vary significantly according to sex, age, or treatment approach (monotherapy versus combination therapy).

Conclusion: In pediatric oncology patients, ICFIs are associated with high mortality, particularly in cases of mucormycosis or proven infections. Improving survival depends on early diagnosis, risk stratification, and rapid management, particularly in patients with neutropenia and fever.

背景和目的:侵袭性皮肤真菌感染(icfi)是危及儿童癌症患者生命的并发症。本研究旨在调查在伊朗设拉子一家转诊肿瘤教学医院住院的儿科癌症患者中icfi的患病率、临床特征和预后。方法:本横断面研究包括2015年至2022年在Amir肿瘤教学医院住院的恶性肿瘤和疑似icfi的儿科患者。诊断基于EORTC/MSG标准,并通过临床、微生物学和组织病理学方法进行确认。数据分析采用描述性统计、Kaplan-Meier生存分析和比较检验,显著性阈值为p。结果:24例患者中,男孩占58.3%,1-5岁占45.8%。急性淋巴细胞白血病是最常见的恶性肿瘤(27.3%)。Mucoralean fungi(36.4%)和Aspergillus(59.1%)最为常见。总生存率为54.2%。已证实的icfi患者的预后最差,到第26个月生存率降至零。CRP水平较低和发热性中性粒细胞减少的患者预后较好(p结论:在儿科肿瘤患者中,icfi与高死亡率相关,特别是在毛霉病或确诊感染的病例中。提高生存率取决于早期诊断、风险分层和快速管理,特别是对中性粒细胞减少症和发热患者。
{"title":"Mortality and Treatment Outcomes in Pediatric Malignancy Patients with Invasive Cutaneous Fungal Infections: Evaluating the Impact of Combination Therapy and Surgical Debridement, Experience from Referral Oncology Teaching Hospital.","authors":"Seyed Reza Abdipour Mehrian, Hadi Mottaghipisheh, Hadis Jafarian, Fatemeh Homayounifar, Alireza Abbasi, Yaser Pourasghar, Fateme Noushadi, Armina Farkarian, Elahe Meftah, Sadra Valiee, Ali Amanati","doi":"10.1007/s11046-025-01004-x","DOIUrl":"10.1007/s11046-025-01004-x","url":null,"abstract":"<p><strong>Background and aims: </strong>Invasive cutaneous fungal infections (ICFIs) are life-threatening complications in pediatric cancer patients. This study aimed to investigate the prevalence, clinical characteristics, and outcomes of ICFIs among pediatric cancer patients hospitalized at a referral oncology teaching Hospital in Shiraz, Iran.</p><p><strong>Methods: </strong>This cross-sectional study included pediatric patients with malignancies and suspected ICFIs who were admitted to the Amir Oncology Teaching Hospital between 2015 and 2022. Diagnosis was based on the EORTC/MSG criteria and confirmed using clinical, microbiological, and histopathological methods. Data were analyzed using descriptive statistics, Kaplan-Meier survival analysis, and comparative tests, with a significance threshold of p < 0.05.</p><p><strong>Results: </strong>Among the 24 patients, 58.3% were boys, and 45.8% were aged 1-5 years. Acute lymphoblastic leukemia was the most common malignancy (27.3%). Mucoralean fungi (36.4%) and Aspergillus (59.1%) were the most common. The overall survival rate was 54.2%. Proven ICFIs had the poorest outcomes, with a survival probability declining to zero by month 26. Patients with lower CRP levels and febrile neutropenia had better outcomes (p < 0.001 and p = 0.041, respectively), but survival rates did not vary significantly according to sex, age, or treatment approach (monotherapy versus combination therapy).</p><p><strong>Conclusion: </strong>In pediatric oncology patients, ICFIs are associated with high mortality, particularly in cases of mucormycosis or proven infections. Improving survival depends on early diagnosis, risk stratification, and rapid management, particularly in patients with neutropenia and fever.</p>","PeriodicalId":19017,"journal":{"name":"Mycopathologia","volume":"190 6","pages":"92"},"PeriodicalIF":2.9,"publicationDate":"2025-09-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145150231","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Genome Sequences and Antifungal Susceptibility of Candida auris from a Patient with Atopic Dermatitis. 1例特应性皮炎患者耳念珠菌的基因组序列和抗真菌敏感性。
IF 2.9 3区 生物学 Q2 MYCOLOGY Pub Date : 2025-09-25 DOI: 10.1007/s11046-025-01000-1
Taeyune Kim, Minseok Bae, Jiwon Bang, Jiwon Jeon, Yong-Joon Cho, Jin Park, Won Hee Jung

The whole-genome sequencing of two Candida auris isolates from the skin lesions of a Korean head and neck atopic dermatitis patient classified them within clade II. The isolates were susceptible to common antifungals. This study provides valuable genomic data for understanding the epidemiology and antifungal response of this emerging pathogen.

从韩国头颈部特应性皮炎患者皮肤损伤中分离的两株耳念珠菌的全基因组测序将它们归类为II支。分离株对常见的抗真菌药物敏感。这项研究为了解这种新出现的病原体的流行病学和抗真菌反应提供了有价值的基因组数据。
{"title":"Genome Sequences and Antifungal Susceptibility of Candida auris from a Patient with Atopic Dermatitis.","authors":"Taeyune Kim, Minseok Bae, Jiwon Bang, Jiwon Jeon, Yong-Joon Cho, Jin Park, Won Hee Jung","doi":"10.1007/s11046-025-01000-1","DOIUrl":"10.1007/s11046-025-01000-1","url":null,"abstract":"<p><p>The whole-genome sequencing of two Candida auris isolates from the skin lesions of a Korean head and neck atopic dermatitis patient classified them within clade II. The isolates were susceptible to common antifungals. This study provides valuable genomic data for understanding the epidemiology and antifungal response of this emerging pathogen.</p>","PeriodicalId":19017,"journal":{"name":"Mycopathologia","volume":"190 6","pages":"91"},"PeriodicalIF":2.9,"publicationDate":"2025-09-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12464129/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145150227","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prognostic Value of Serum (1→3)-β-D-Glucan Levels in Patients with Candidemia Stratified by Compliance with Candida Bundle: A Multicenter Retrospective Cohort Study (2016-2023). 念珠菌束依从性分层患者血清(1→3)-β- d -葡聚糖水平的预后价值:一项多中心回顾性队列研究(2016-2023)
IF 2.9 3区 生物学 Q2 MYCOLOGY Pub Date : 2025-09-22 DOI: 10.1007/s11046-025-00999-7
Hidemasa Akazawa, Shinnosuke Fukushima, Toshie Higuchi, Tomoko Miyoshi, Yasuhiro Nakano, Koji Iio, Yukinobu Akamatsu, Yuto Haruki, Yoshitaka Iwamoto, Shuichi Tanaka, Shun Fujisato, Soichiro Ako, Hideharu Hagiya

Background: Candidemia is a severe systemic infection with a high mortality risk. While β-D-glucan (BDG) serves as a diagnostic biomarker, its prognostic value in candidemia, particularly in association with Candida bundle compliance, remains unclear.

Methods: In this retrospective multicenter cohort study, we evaluated 96 patients with candidemia across nine Japanese hospitals between 2016 and 2023. Candida bundle compliance was assessed using five key components: central venous catheter removal within 24 h of diagnosis, appropriate initial antifungal therapy, ophthalmologic examination, follow-up blood cultures until clearance, and antifungal therapy for at least two weeks post-clearance. Analyses stratified patients by serum BDG status (positive/negative) and compliance with the Candida bundle (high: 4-5 points; low: 0-3 points). The primary outcome was 30-day mortality, and the secondary outcome was defined as endophthalmitis incidence.

Results: Of 96 eligible patients with candidemia, 70 (72.9%) were BDG-positive and 26 (27.1%) were BDG-negative. The overall 30-day mortality was 17.7%. Among BDG-positive patients, 15 (21.4%) died, while 2 (7.7%) died in BDG-negative cohorts (p = 0.09). Serum BDG positivity demonstrated a statistically significant association with decreased survival rates in the low bundle adherence group (p = 0.02), whereas this correlation was not observed among patients in the high-compliance cohort (p = 0.66). Endophthalmitis occurred in 25.0% of patients, without significant correlation to serum BDG status. C. albicans was associated with a significantly higher incidence of endophthalmitis compared with non-albicans species (45.7% vs. 8.9%).

Conclusions: Serum BDG positivity potentially correlates with worse survival in candidemia, particularly in patients with low bundle compliance. This emphasizes the importance of adherence to standardized Candida management protocols for optimizing patient outcomes.

背景:念珠菌是一种严重的全身性感染,死亡率高。虽然β- d -葡聚糖(BDG)作为一种诊断性生物标志物,但其在念珠菌病中的预后价值,特别是与念珠菌束依从性的关系尚不清楚。方法:在这项回顾性多中心队列研究中,我们评估了2016年至2023年间日本9家医院的96例念珠菌患者。念珠菌束依从性通过五个关键组成部分进行评估:在诊断后24小时内取出中心静脉导管,适当的初始抗真菌治疗,眼科检查,随访血培养直到清除,以及清除后至少两周的抗真菌治疗。根据血清BDG状态(阳性/阴性)和念珠菌束依从性对患者进行分层分析(高:4-5分,低:0-3分)。主要终点为30天死亡率,次要终点为眼内炎发生率。结果:96例符合条件的念珠菌病患者中,bdg阳性70例(72.9%),bdg阴性26例(27.1%)。总体30天死亡率为17.7%。bdg阳性组15例(21.4%)死亡,bdg阴性组2例(7.7%)死亡(p = 0.09)。血清BDG阳性与低束依从组的生存率降低有统计学意义(p = 0.02),而在高束依从组的患者中没有观察到这种相关性(p = 0.66)。25.0%的患者发生眼内炎,与血清BDG状态无显著相关性。与非白色念珠菌相比,白色念珠菌与眼内炎的发生率明显更高(45.7%比8.9%)。结论:血清BDG阳性可能与念珠菌病患者较差的生存率相关,特别是在低束依从性患者中。这强调了遵守标准化念珠菌管理方案对优化患者预后的重要性。
{"title":"Prognostic Value of Serum (1→3)-β-D-Glucan Levels in Patients with Candidemia Stratified by Compliance with Candida Bundle: A Multicenter Retrospective Cohort Study (2016-2023).","authors":"Hidemasa Akazawa, Shinnosuke Fukushima, Toshie Higuchi, Tomoko Miyoshi, Yasuhiro Nakano, Koji Iio, Yukinobu Akamatsu, Yuto Haruki, Yoshitaka Iwamoto, Shuichi Tanaka, Shun Fujisato, Soichiro Ako, Hideharu Hagiya","doi":"10.1007/s11046-025-00999-7","DOIUrl":"10.1007/s11046-025-00999-7","url":null,"abstract":"<p><strong>Background: </strong>Candidemia is a severe systemic infection with a high mortality risk. While β-D-glucan (BDG) serves as a diagnostic biomarker, its prognostic value in candidemia, particularly in association with Candida bundle compliance, remains unclear.</p><p><strong>Methods: </strong>In this retrospective multicenter cohort study, we evaluated 96 patients with candidemia across nine Japanese hospitals between 2016 and 2023. Candida bundle compliance was assessed using five key components: central venous catheter removal within 24 h of diagnosis, appropriate initial antifungal therapy, ophthalmologic examination, follow-up blood cultures until clearance, and antifungal therapy for at least two weeks post-clearance. Analyses stratified patients by serum BDG status (positive/negative) and compliance with the Candida bundle (high: 4-5 points; low: 0-3 points). The primary outcome was 30-day mortality, and the secondary outcome was defined as endophthalmitis incidence.</p><p><strong>Results: </strong>Of 96 eligible patients with candidemia, 70 (72.9%) were BDG-positive and 26 (27.1%) were BDG-negative. The overall 30-day mortality was 17.7%. Among BDG-positive patients, 15 (21.4%) died, while 2 (7.7%) died in BDG-negative cohorts (p = 0.09). Serum BDG positivity demonstrated a statistically significant association with decreased survival rates in the low bundle adherence group (p = 0.02), whereas this correlation was not observed among patients in the high-compliance cohort (p = 0.66). Endophthalmitis occurred in 25.0% of patients, without significant correlation to serum BDG status. C. albicans was associated with a significantly higher incidence of endophthalmitis compared with non-albicans species (45.7% vs. 8.9%).</p><p><strong>Conclusions: </strong>Serum BDG positivity potentially correlates with worse survival in candidemia, particularly in patients with low bundle compliance. This emphasizes the importance of adherence to standardized Candida management protocols for optimizing patient outcomes.</p>","PeriodicalId":19017,"journal":{"name":"Mycopathologia","volume":"190 6","pages":"90"},"PeriodicalIF":2.9,"publicationDate":"2025-09-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12454490/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145125261","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Case of Feline Favus Due to Nannizzia incurvata With Low Azole Susceptibility. 低唑药敏的突发性南霉病猫病1例。
IF 2.9 3区 生物学 Q2 MYCOLOGY Pub Date : 2025-09-20 DOI: 10.1007/s11046-025-00991-1
Hisanori Mutoh, Koichi Makimura, Rui Kano
{"title":"A Case of Feline Favus Due to Nannizzia incurvata With Low Azole Susceptibility.","authors":"Hisanori Mutoh, Koichi Makimura, Rui Kano","doi":"10.1007/s11046-025-00991-1","DOIUrl":"10.1007/s11046-025-00991-1","url":null,"abstract":"","PeriodicalId":19017,"journal":{"name":"Mycopathologia","volume":"190 5","pages":"89"},"PeriodicalIF":2.9,"publicationDate":"2025-09-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145092255","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Sensitivity and Specificity of Polymerase Chain Reaction in Blood and Bronchoalveolar Lavage Samples for Mucormycosis: A Bayesian Diagnostic Test Accuracy Meta-Analysis. 血液和支气管肺泡灌洗液中聚合酶链反应对毛霉病的敏感性和特异性:贝叶斯诊断测试准确性荟萃分析
IF 2.9 3区 生物学 Q2 MYCOLOGY Pub Date : 2025-09-17 DOI: 10.1007/s11046-025-00996-w
Valliappan Muthu, Ritesh Agarwal, Sahajal Dhooria, Inderpaul Singh Sehgal, Kuruswamy Thurai Prasad, Shivaprakash M Rudramurthy, Ashutosh N Aggarwal, Arunaloke Chakrabarti

Background: The utility of polymerase chain reaction (PCR) for diagnosing mucormycosis is uncertain. We conducted a diagnostic test accuracy meta-analysis to determine the performance of Mucorales PCR.

Methods: We systematically reviewed PubMed, Embase, and Cochrane Central databases to identify studies reporting Mucorales PCR (blood or bronchoalveolar lavage fluid [BALF] samples) in at least 10 suspected mucormycosis cases. We pooled sensitivity and specificity using Bayesian (weak and two informative priors) and frequentist methods. Subgroup analyses included middle vs. high-income countries, risk factors (hematological diseases vs. others), study design, assay type (commercial vs. in-house), and testing protocol (serial testing vs. single-time PCR). We assessed the effect of the number of blood tests performed per participant on sensitivity using multivariable meta-regression.

Results: We identified 1524 citations, of which 36 studies (41 datasets, n = 6627 participants; 16,613 samples) were included. The pooled sensitivity and specificity (with 95% credible interval) by Bayesian weak priors (primary analysis) were 51% (34-67%) and 97% (95-98%) for blood; 64% (50-76%) and 97% (95-98%) for BALF samples. We found wide variation in sensitivity, with a 14% increment for every additional blood sample tested per patient. Studies from middle-income countries reported a significantly lower pooled sensitivity (31 vs. 68%) in blood samples and lower specificity in BALF (72 vs. 98%) than high-income countries. No other subgroups showed significant differences.

Conclusion: Mucorales PCR was highly specific but poorly sensitive in blood, and moderately sensitive with high specificity in BALF. Before routine implementation, further well-designed studies from diverse settings and underrepresented regions are needed.

背景:聚合酶链反应(PCR)在毛霉病诊断中的应用尚不确定。我们进行了诊断测试准确性荟萃分析,以确定Mucorales PCR的性能。方法:我们系统地回顾了PubMed、Embase和Cochrane Central数据库,以确定在至少10例疑似毛霉病病例中报告了Mucorales PCR(血液或支气管肺泡灌洗液[BALF]样本)的研究。我们使用贝叶斯(弱先验和两个信息先验)和频率分析方法合并敏感性和特异性。亚组分析包括中等收入国家与高收入国家、危险因素(血液病与其他疾病)、研究设计、检测类型(商业检测与内部检测)和检测方案(系列检测与单次PCR)。我们使用多变量meta回归评估每位参与者进行的血液检查次数对敏感性的影响。结果:共收录1524篇引文,其中36篇研究(41个数据集,n = 6627名参与者,16613个样本)被纳入。贝叶斯弱先验(初步分析)对血液的综合敏感性和特异性(95%可信区间)分别为51%(34-67%)和97% (95-98%);BALF样品为64%(50-76%)和97%(95-98%)。我们发现灵敏度差异很大,每位患者每增加一份血液样本,灵敏度就会增加14%。来自中等收入国家的研究报告,与高收入国家相比,血液样本的综合敏感性(31%对68%)和BALF的特异性(72%对98%)明显较低。其他亚组无显著差异。结论:Mucorales PCR在血液中特异性高,敏感性低,在BALF中敏感性中等,特异性高。在常规实施之前,需要进一步从不同环境和代表性不足的地区进行精心设计的研究。
{"title":"Sensitivity and Specificity of Polymerase Chain Reaction in Blood and Bronchoalveolar Lavage Samples for Mucormycosis: A Bayesian Diagnostic Test Accuracy Meta-Analysis.","authors":"Valliappan Muthu, Ritesh Agarwal, Sahajal Dhooria, Inderpaul Singh Sehgal, Kuruswamy Thurai Prasad, Shivaprakash M Rudramurthy, Ashutosh N Aggarwal, Arunaloke Chakrabarti","doi":"10.1007/s11046-025-00996-w","DOIUrl":"10.1007/s11046-025-00996-w","url":null,"abstract":"<p><strong>Background: </strong>The utility of polymerase chain reaction (PCR) for diagnosing mucormycosis is uncertain. We conducted a diagnostic test accuracy meta-analysis to determine the performance of Mucorales PCR.</p><p><strong>Methods: </strong>We systematically reviewed PubMed, Embase, and Cochrane Central databases to identify studies reporting Mucorales PCR (blood or bronchoalveolar lavage fluid [BALF] samples) in at least 10 suspected mucormycosis cases. We pooled sensitivity and specificity using Bayesian (weak and two informative priors) and frequentist methods. Subgroup analyses included middle vs. high-income countries, risk factors (hematological diseases vs. others), study design, assay type (commercial vs. in-house), and testing protocol (serial testing vs. single-time PCR). We assessed the effect of the number of blood tests performed per participant on sensitivity using multivariable meta-regression.</p><p><strong>Results: </strong>We identified 1524 citations, of which 36 studies (41 datasets, n = 6627 participants; 16,613 samples) were included. The pooled sensitivity and specificity (with 95% credible interval) by Bayesian weak priors (primary analysis) were 51% (34-67%) and 97% (95-98%) for blood; 64% (50-76%) and 97% (95-98%) for BALF samples. We found wide variation in sensitivity, with a 14% increment for every additional blood sample tested per patient. Studies from middle-income countries reported a significantly lower pooled sensitivity (31 vs. 68%) in blood samples and lower specificity in BALF (72 vs. 98%) than high-income countries. No other subgroups showed significant differences.</p><p><strong>Conclusion: </strong>Mucorales PCR was highly specific but poorly sensitive in blood, and moderately sensitive with high specificity in BALF. Before routine implementation, further well-designed studies from diverse settings and underrepresented regions are needed.</p>","PeriodicalId":19017,"journal":{"name":"Mycopathologia","volume":"190 5","pages":"88"},"PeriodicalIF":2.9,"publicationDate":"2025-09-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145081197","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Mycopathologia
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1